ORIGINAL RESEARCH
Accepted on 22 Jul 2025
GPATCH3, a splicing regulator that facilitates tumor immune evasion via the modulation of ATPase activity of DHX15
doi 10.3389/fimmu.2025.1612461
- 172 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Post-Transcriptional Modifications in Cancer Immunity and Immunotherapy
Post-Transcriptional Modifications in Cancer Immunity and Immunotherapy
3,511
Total downloads
14k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 16 Apr 2025
Multi-omics landscape of alternative splicing in diffuse midline glioma reveals immune- and neural-driven subtypes with implications for spliceosome-targeted therapy
doi 10.3389/fimmu.2025.1587009
- 1,744 views
REVIEW
Published on 24 Mar 2025
Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target
doi 10.3389/fimmu.2025.1523503
- 1,167 views
MINI REVIEW
Published on 11 Mar 2025
PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy
doi 10.3389/fimmu.2025.1537615
- 1,393 views
ORIGINAL RESEARCH
Published on 04 Dec 2024
Alternative splicing regulation by tumor suppressing subtransferable candidate 4: a pathway to tumor suppression
doi 10.3389/fimmu.2024.1474527
- 1,264 views
MINI REVIEW
Published on 11 Jul 2024
Neoantigens in cancer immunotherapy: focusing on alternative splicing
doi 10.3389/fimmu.2024.1437774
- 4,213 views
- 14 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore